2024
Feasibility of a prospective pediatric melanocytic tumor clinical trial: A report of multidisciplinary clinician survey data from the Children's Oncology Group Rare Tumor Committee
Mitchell S, Christison‐Lagay E, Aldrink J, Sargen M, Laetsch T, Austin M, Jen M, Gartrell R, Karunamurthy A, Kirkwood J, Pappo A, Seynnaeve B. Feasibility of a prospective pediatric melanocytic tumor clinical trial: A report of multidisciplinary clinician survey data from the Children's Oncology Group Rare Tumor Committee. Pediatric Blood & Cancer 2024, 71: e31312. PMID: 39252525, PMCID: PMC11583290, DOI: 10.1002/pbc.31312.Peer-Reviewed Original Research
2023
Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective
Schultz K, Chintagumpala M, Piao J, Chen K, Shah R, Gartrell R, Christison-Lagay E, Pashnakar F, Berry J, O'Neill A, Vasta L, Flynn A, Mitchell S, Seynnaeve B, Rosenblum J, Potter S, Kamihara J, Rodriguez-Galindo C, Hawkins D, Laetsch T. Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective. 2023, 2: 100024. PMID: 37829670, PMCID: PMC10566015, DOI: 10.1016/j.ejcped.2023.100024.Peer-Reviewed Original ResearchTumor CommitteeStromal tumorsDesmoplastic small round cell tumorSmall round cell tumorGastrointestinal stromal tumorsNonmelanoma skin cancerRound cell tumorGonadal stromal tumorPleuropulmonary blastomaRare tumorAdrenocortical carcinomaNeuroendocrine tumorsCell tumorsRare cancersChildhood cancerColorectal carcinomaPancreatic tumorsNasopharyngeal carcinomaThyroid carcinomaHigh-quality researchCarcinomaSkin cancerTumorsYoung adultsCancerChildren's Oncology Group's 2023 blueprint for research: Rare tumors
Schultz K, Chintagumpala M, Piao J, Chen K, Gartrell R, Christison‐Lagay E, Berry J, Shah R, Laetsch T, Committee T. Children's Oncology Group's 2023 blueprint for research: Rare tumors. Pediatric Blood & Cancer 2023, 70: e30574. PMID: 37458616, PMCID: PMC10529839, DOI: 10.1002/pbc.30574.Peer-Reviewed Original Research